Siegmund Karasch
Directeur/Bestuurslid bij DEUTSCHE BIOTECH INNOVATIV AG
Profiel
Siegmund Karasch is the founder of AdrenoMed AG.
He is currently a Member-Supervisory Board at Deutsche Biotech Innovativ AG since 2018.
Previously, he worked as Chief Executive & Operating Officer at InVivo BioTech Services GmbH.
He completed his undergraduate degree from Hochschule für Technik und Wirtschaft Berlin in 1993.
Actieve functies van Siegmund Karasch
| Bedrijven | Functie | Begin |
|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Directeur/Bestuurslid | 05-07-2018 |
Eerdere bekende functies van Siegmund Karasch
| Bedrijven | Functie | Einde |
|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Oprichter | 01-01-2014 |
InVivo BioTech Services GmbH
 InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Algemeen Directeur | - |
Opleiding van Siegmund Karasch
| Hochschule für Technik und Wirtschaft Berlin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Finance |
| Bedrijven in privébezit | 2 |
|---|---|
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
